TNNT2 and cancer: These findings suggest that hs-cTnT and NT-proBNP levels are not only indictive of cardiac events and mortality in cancer patients17, 18, 19, 20 but also predictive of future incident cancer risk in individuals with subclinical CVD.PerspectivesCOMPETENCY IN MEDICAL KNOWLEDGE: Higher baseline levels of hs-cTnT and NT-proBNP are strong predictors of an increased risk of developing incident cancer events, independent of traditional cardiovascular risk factors.